Statins and aspirin in chronic kidney disease: What does the UK-HARP-I trial tell us?

American Journal of Kidney Diseases

Volumn 45, Issue 3, 2005, Pages 607-609

  Krane, Vera ^a   Wanner, Christoph ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

BLEEDING; BLEEDING TIME; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEMODIALYSIS; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; PILOT STUDY; PRACTICE GUIDELINE; RISK ASSESSMENT; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT OUTCOME;

EID: 14844311917     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.01.011     Document Type: Editorial

References (11)

1. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86 (Erratum in BMJ 324:141, 2002)
2. S.M. Grundy, J.I. Cleeman, C.N.B. Merz Coordinating Committee of the National Cholesterol Education Program Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
3. R.N. Foley, P.S. Parfrey, M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 suppl 3 1998 S112 S119
4. A.S. Go, G.M. Chertow, D. Fan Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
5. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Management of Dyslipidemias in Patients With Kidney Disease Am J Kidney Dis 41 suppl 3 2003 S1 S91
6. European Best Practice Guidelines for Haemodialysis (Part 1) Section VII Vascular disease and risk factors Nephrol Dial Transplant 17 suppl 7 2002 S88 S109
7. C. Baigent, M. Landray, C. Leaper First United Kingdom Heart and Renal Protection (UK-HARP-I) study Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease Am J Kidney Dis 45 2005 473 484
8. M. Livio, A. Benigni, G. Vigano Moderate doses of aspirin and risk of bleeding in renal failure Lancet 1 1986 414 416
9. F. Gaspari, G. Vigano, S. Orisio Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition J Clin Invest 79 1987 1788 1797
10. C. Wanner, V. Krane, W. März Die Deutsche Diabetes Dialyse Studie (4D) Study Group Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D Study) Demographic and baseline characteristics Kidney Blood Press Res 27 2004 259 266
11. M. Tonelli, C. Isles, G.C. Curhan Effect of pravastatin on cardiovascular events in people with chronic kidney disease Circulation 110 2004 1557 1563